Article
Influence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemia.
Pediatrics international : official journal of the Japan Pediatric Society - 1 Aug 2015
Suzuki Ryoko, Fukushima Hiroko, Noguchi Emiko, Tsuchida Masahiro, Kiyokawa Nobutaka, Koike Kazutoshi, Ma Enbo, Takahashi Hideto, Kobayashi Chie, Nakajima-Yamaguchi Ryoko, Sakai Aiko, Saito Makoto, Iwabuchi Atsushi, Kato Keisuke, Nakao Tomohei, Yoshimi Ai, Sumazaki Ryo, Fukushima Takashi
Abstract excerpt
BACKGROUND: Management of the adverse effects of chemotherapy is essential to improve outcome of children with leukemia. Some genetic polymorphisms can predict treatment-related toxicity, and be used individually in dose modification of 6-mercaptopurine (6-MP) and methotrexate (MTX) in maintenance therapy for childhood acute lymphoblastic leukemia (ALL). We investigated associations between clinical course and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
